Doctors, lawyers, pharmaceutical, life science consulting firms and providers of health care are all very closely the development of government regulations of DTC genetic tests.

From this post, the federal regulations differ from state to state, each with its own regulations, total or partial or complete restrictions. Only 12 states allow direct to consumer testing, 13 have full restrictions in place and 24 are partial limitations to what they to allow. At present, both in New York and California have full restrictions against direct consumers of genetic testing, and companies wishing to provide these services wonder if other states follow its example. Many of these companies are located in the U.S. Given these loose standards. Countries like the UK are not as attractive to the business and strict standards are already underway.

But many consumers are keeping a close watch on these events as well. There's definitely three factions in the game, they want it, those who do not and those who agree that partial restrictions are fine.

Advocates of genetic testing DTC feel that helps consumers take a proactive approach to their own medical care. Many believe that testing for diseases such as cardiovascular diseases, cholesterol problems or encourage people to seek professional help earlier than usual, and in most cases, even before symptoms occur. Also are in support of genealogical testing can alert people to the health concerns that may be inherited.

For those against DTC testing, the problems are more moral and ethical. Their concern focuses on the many emotional, social and even financial factors that could be overlooked without the guidance of a health professional. Other moral concerns might be that the day would come, for example, when health insurers demand genetic tests before approving the policy, or the demand of employers before recruitment for the posts.

Supporters of partial regulation can see both good and bad. Some of the simpler tests could perhaps be left to consumers. The more complicated tests, and those with the greatest impact on the lives consumers, should be administered with both medical and psychological orientation of the health professional.

Still others fear that the lack federal regulators would allow companies to genetic testing to take advantage of some desperate consumers and advertise the necessary services or falsely charge exorbitant fees.

And then, of course, is the argument that without the interpretation of test results for relevant professionals, consumers could make poor decisions regarding their current and future health.

It is, to say the least, a more complex issue and one that is experiencing very close monitoring worldwide.

If you enjoyed this article, please do not hesitate to send to your site or blog and send this link to your friends. Have a great day!

No forget to visit our blog.

About the Author:

Nigel Smart is a
pharmaceutical”>http://www.smartconsultinggrp.com”>pharmaceutical
consultant with extensive experience in the biotechnology and pharmaceutical industry. With Denise Smart, he manages Smart Consulting Group. Visit their blog at
www.smartconsultinggroup.com/blog

Article Source: ArticlesBase.com – DTC Genetic Tests – The Good, The Bad and the Future

Family History Skills Courses at the Society of Genealogists